Clinical Trial Update: Multi-CAR T Cell Therapy in the Treatment of Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update describes a multi-CAR T cell therapy being studied for multiple myeloma across Phase 1 and Phase 2, with the status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Multi-CAR T Cell Therapy

Snippet

Sponsor: Shenzhen Geno-Immune Medical Institute | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: UNKNOWN